Entao Li
Hefei, 230026, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 18, 2026
Receptor binding domain-independent pancoronavirus vaccine design by fusion of conserved T/B Epitopes.
Journal: Emerging microbes & infections
Published: February 11, 2026
Corrigendum to "Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation" [J. Pharm. Anal. 13 (2023) 11-23].
Journal: Journal of pharmaceutical analysis
Published: January 15, 2026
Next-Generation Vaccines for Co-Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI-Driven Antigen Design.
Journal: Transboundary and emerging diseases
Published: September 08, 2025
Broadly neutralizing nanobodies target a defined structural pivot site on the RSV fusion protein.
Journal: EMBO molecular medicine
Published: August 23, 2025
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus.
Journal: Nature communications
Published: August 04, 2025
A single-chain mRNA vaccine co-expressing GPC and NP provides complete protection against lethal Dabie bandavirus challenge in mice.
Journal: Molecular therapy. Nucleic acids
Published: July 21, 2025
Polyethyleneimine-modified Laminarin nanoparticles enhance antigen delivery to lymph nodes by inducing transient inflammatory responses at the injection site.
Journal: Materials today. Bio
Published: July 04, 2025
Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay.
Journal: Microbiology spectrum
Published: March 25, 2025
Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 01, 2025
ALC-0315 Lipid-Based mRNA LNP Induces Stronger Cellular Immune Responses Postvaccination.
Journal: Molecular pharmaceutics
Published: January 15, 2025
Last Updated: 09/26/2026